| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0046 | 0.9 |